(S)-Benzyl 2-(3-Amino-4-((S)-2-aminohexanamido)-benzamido)-3-(1H-indol-3-yl)propanoate

ID: ALA3416726

Chembl Id: CHEMBL3416726

PubChem CID: 118734293

Max Phase: Preclinical

Molecular Formula: C31H35N5O4

Molecular Weight: 541.65

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC[C@H](N)C(=O)Nc1ccc(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)OCc2ccccc2)cc1N

Standard InChI:  InChI=1S/C31H35N5O4/c1-2-3-12-24(32)30(38)35-27-15-14-21(16-25(27)33)29(37)36-28(31(39)40-19-20-9-5-4-6-10-20)17-22-18-34-26-13-8-7-11-23(22)26/h4-11,13-16,18,24,28,34H,2-3,12,17,19,32-33H2,1H3,(H,35,38)(H,36,37)/t24-,28-/m0/s1

Standard InChI Key:  LCOBAHRSJLHENC-CUBQBAPOSA-N

Alternative Forms

  1. Parent:

    ALA3416726

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNPEP Tchem Cystinyl aminopeptidase (313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 541.65Molecular Weight (Monoisotopic): 541.2689AlogP: 4.29#Rotatable Bonds: 12
Polar Surface Area: 152.33Molecular Species: NEUTRALHBA: 6HBD: 5
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.71CX Basic pKa: 8.28CX LogP: 4.18CX LogD: 3.25
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.13Np Likeness Score: -0.38

References

1. Papakyriakou A, Zervoudi E, Tsoukalidou S, Mauvais FX, Sfyroera G, Mastellos DC, van Endert P, Theodorakis EA, Vourloumis D, Stratikos E..  (2015)  3,4-diaminobenzoic acid derivatives as inhibitors of the oxytocinase subfamily of M1 aminopeptidases with immune-regulating properties.,  58  (3): [PMID:25635706] [10.1021/jm501867s]

Source